Guidelines for the diagnosis and management of aplastic anaemia.
JCW Marsh, SE Ball, J Cavenagh… - British journal of …, 2009 - search.ebscohost.com
The article presents the guideline for the diagnosis and management of aplastic anaemia. It
aims to provide healthcare professionals with clear guidance on the diagnosis and …
aims to provide healthcare professionals with clear guidance on the diagnosis and …
Current concepts in the pathophysiology and treatment of aplastic anemia
Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone
marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia …
marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia …
[PDF][PDF] 单倍型供者造血干细胞移植治疗重型再生障碍性贫血的单中心研究
杜志丛， 赵艳丽， 曹星玉， 刘德琰， 熊敏… - 临床血液学 …, 2023 - lcxyen.whuhzzs.com
目的: 探讨单倍型造血干细胞移植(haplo-HSCT) 治疗重型再生障碍性贫血(SAA) 的疗效. 方法:
回顾性分析2012 年9 月—2019 年11 月接受HID-HSCT 的120 例儿童和成人SAA …
回顾性分析2012 年9 月—2019 年11 月接受HID-HSCT 的120 例儿童和成人SAA …
Aplastic anemia
NS Young, P Scheinberg… - Current opinion in …, 2008 - journals.lww.com
Evidence has accumulated in the recent years further corroborating an immune-mediated
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …
[HTML][HTML] Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe …
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body
irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective …
irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective …
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic …
We evaluated a novel alemtuzumab-based conditioning regimen in HSCT for acquired
severe aplastic anemia (SAA). In a multicenter retrospective study, 50 patients received …
severe aplastic anemia (SAA). In a multicenter retrospective study, 50 patients received …
Retreatment with rabbit anti‐thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia
P Scheinberg, O Nunez… - British journal of …, 2006 - Wiley Online Library
The management of patients with severe aplastic anaemia (SAA) who do not have a
matched sibling donor and fail a course of horse anti‐thymocyte globulin (h …
matched sibling donor and fail a course of horse anti‐thymocyte globulin (h …
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
HJ Deeg, M O'Donnell, J Tolar, R Agarwal, RE Harris… - Blood, 2006 - ashpublications.org
In 87 patients with aplastic anemia who failed to respond to immunosuppressive treatment,
we determined the minimal dose of total body irradiation (TBI) required when added to …
we determined the minimal dose of total body irradiation (TBI) required when added to …
Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine
OBJECTIVE: To determine the long-term outcomes in children with severe aplastic anemia
(SAA) treated with antithymocyte globulin (ATG) and cyclosporine (CsA) through a …
(SAA) treated with antithymocyte globulin (ATG) and cyclosporine (CsA) through a …
The diagnosis and treatment of aplastic anemia: a review
M Miano, C Dufour - International journal of hematology, 2015 - Springer
Aplastic anemia is a rare disorder characterized by suppression of bone marrow function
resulting in progressive pancytopenia. A trigger-related abnormal T cell response facilitated …
resulting in progressive pancytopenia. A trigger-related abnormal T cell response facilitated …